Deprescribing antihypertensives in patients with multimorbidity

Please use this identifier to cite or link to this item: https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/664

Full metadata record

DC Field	Value	Language
dc.contributor.author	External author(s) only	-
dc.date.accessioned	2020-12-17T15:15:46Z	-
dc.date.available	2020-12-17T15:15:46Z	-
dc.date.issued	2020-10	-
dc.identifier.citation	James P Sheppard AND Rupert A Payne. Deprescribing antihypertensives in patients with multimorbidity. Prescriber October 2020	en
dc.identifier.issn	09596682	-
dc.identifier.uri	https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/664	-
dc.description.abstract	Deprescribing preventative medications such as antihypertensives may reduce adverse events in some older adults, leading to improved quality of life. The Optimising Treatment for Mild Systolic Hypertension in the Elderly (OPTIMISE) trial examined the safety and efficacy of antihypertensive deprescribing in older patients taking more than one treatment for hypertension. This article discusses the findings of the study and their implications for clinical practice.	en
dc.description.sponsorship	Supported by the NIHR (CLAHRC)	en
dc.description.uri	https://doi.org/10.1002/psb.1870	en
dc.language.iso	en	en
dc.subject	Hypertension	en
dc.subject	Multi Morbidity	en
dc.subject	De-prescribing	en
dc.subject	Older People	en
dc.title	Deprescribing antihypertensives in patients with multimorbidity	en
dc.type	Article	en
Appears in Collections:	Cardiovascular Diseases

Files in This Item:

There are no files associated with this item.

DSpace JSPUI